Dnca Finance Has $14.58 Million Stake in Danaher Co. (NYSE:DHR)

Dnca Finance lifted its position in Danaher Co. (NYSE:DHR - Free Report) by 17.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 63,500 shares of the conglomerate's stock after purchasing an additional 9,600 shares during the quarter. Danaher accounts for approximately 1.1% of Dnca Finance's holdings, making the stock its 26th biggest holding. Dnca Finance's holdings in Danaher were worth $14,576,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in DHR. Kentucky Retirement Systems Insurance Trust Fund lifted its position in Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after buying an additional 2,202 shares in the last quarter. ORG Partners LLC increased its holdings in shares of Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after purchasing an additional 2,559 shares in the last quarter. Generate Investment Management Ltd acquired a new position in Danaher during the 4th quarter worth $8,044,000. Compass Capital Management Inc. boosted its position in Danaher by 4.8% in the 4th quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock valued at $54,615,000 after buying an additional 10,994 shares during the last quarter. Finally, Channing Global Advisors LLC raised its position in shares of Danaher by 42.8% during the fourth quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate's stock worth $1,301,000 after acquiring an additional 1,698 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on DHR shares. Barclays lifted their price target on shares of Danaher from $205.00 to $215.00 and gave the stock an "overweight" rating in a research report on Tuesday. JPMorgan Chase & Co. reduced their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research report on Tuesday. Guggenheim restated a "buy" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday. Royal Bank of Canada reaffirmed an "outperform" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday. Finally, UBS Group lowered their price target on Danaher from $275.00 to $240.00 and set a "buy" rating for the company in a report on Wednesday. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $264.40.

Danaher Stock Down 0.4 %

DHR stock traded down $0.82 during mid-day trading on Thursday, reaching $195.49. The company had a trading volume of 1,803,594 shares, compared to its average volume of 3,343,456. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The company has a market capitalization of $139.72 billion, a price-to-earnings ratio of 36.99, a PEG ratio of 2.66 and a beta of 0.86. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a 50 day simple moving average of $201.21 and a two-hundred day simple moving average of $225.57.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. As a group, equities analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. This is a positive change from Danaher's previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher's dividend payout ratio is currently 24.85%.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.